| Alan Gy Chang, MD | |
|
3111 Woburn St Ste 201, Bellingham, WA 98226-6610 | |
| (360) 543-5054 | |
| (360) 733-1659 |
| Full Name | Alan Gy Chang |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 35 Years |
| Location | 3111 Woburn St Ste 201, Bellingham, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255398285 | NPI | - | NPPES |
| 8231334 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD00036498 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Michaels Hospital | Stevens point, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
| Aspirus Rhinelander And Tomahawk Hospitals And Clinics Inc | 9335059856 | 309 |
| Praxis Health Pc | 8325941446 | 167 |
News Archive
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Children's Hospital Los Angeles and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA's first NGS panel designed to target biomarkers associated with childhood cancers.
As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a delay in diagnosis. That's when DVT can be fatal.
› Verified 9 days ago
| Entity Name | Aspirus Rhinelander & Tomahawk Hospitals & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144991340 PECOS PAC ID: 9335059856 Enrollment ID: O20031126000706 |
News Archive
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Children's Hospital Los Angeles and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA's first NGS panel designed to target biomarkers associated with childhood cancers.
As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a delay in diagnosis. That's when DVT can be fatal.
› Verified 9 days ago
| Entity Name | Aspirus Stevens Point Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538112230 PECOS PAC ID: 1850358938 Enrollment ID: O20041210000558 |
News Archive
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Children's Hospital Los Angeles and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA's first NGS panel designed to target biomarkers associated with childhood cancers.
As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a delay in diagnosis. That's when DVT can be fatal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alan Gy Chang, MD 3111 Woburn St Ste 201, Bellingham, WA 98226-6610 Ph: (360) 543-5054 | Alan Gy Chang, MD 3111 Woburn St Ste 201, Bellingham, WA 98226-6610 Ph: (360) 543-5054 |
News Archive
Lack of time, knowledge and training in health promotion and lack of success with changing patient behavior were among the top barriers to including effective physical activity counseling in the primary care setting, according to research by The University of Texas School of Public Health, part of The University of Texas Health Science Center at Houston.
SQI Diagnostics Inc., a medical systems automation company focused on evolving laboratory-based biomarker testing, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's automated SQiDworks(TM) Diagnostics Platform and its multiplexed IgXPLEX(TM) rheumatoid arthritis (RA) assay for marketing in the United States.
Children's Hospital Los Angeles and Thermo Fisher Scientific have agreed to develop a next-generation sequencing (NGS)-based panel designed specifically for pediatric cancer research. The assay would be CHLA's first NGS panel designed to target biomarkers associated with childhood cancers.
As many as 600,000 people are affected by deep vein thrombosis (DVT) and pulmonary embolism (PE) every year, and more than half of those are never diagnosed. Some people experience swelling and varying levels of discomfort in the affected area, and some don't feel anything at all. But the symptoms of DVT can be similar to other conditions, like a pulled muscle, and because some people with DVT do not have any symptoms, there is often a delay in diagnosis. That's when DVT can be fatal.
› Verified 9 days ago
Katherine Morgan, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2592 Kwina Rd, Bellingham, WA 98226 Phone: 360-384-0464 | |
Hannah Sheinin, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2979 Squalicum Pkwy, Suite 301, Bellingham, WA 98225 Phone: 360-734-1420 Fax: 360-756-6666 | |
Ankur Mogla, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 410 Birchwood Ave Ste 200, Bellingham, WA 98225 Phone: 360-734-9233 | |
Dr. Sumner Todd Mcallister, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 722 N State St, Bellingham, WA 98225 Phone: 360-752-2865 | |
Amir Gharaei, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3015 Squalicum Pkwy, Suite 140, Bellingham, WA 98225 Phone: 360-788-6112 | |
Scott Michael Letellier, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3301 Squalicum Pkwy, Bellingham, WA 98225 Phone: 360-788-8222 Fax: 360-788-7759 | |
Dr. Sukhjit Singh Shergill, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4545 Cordata Pkwy, Suite 2b, Bellingham, WA 98226 Phone: 360-738-2200 Fax: 360-752-5683 |